Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Change in Inventory (2024 - 2025)

Autolus Therapeutics (AUTL) has disclosed Change in Inventory for 2 consecutive years, with $8.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory changed N/A year-over-year to $8.6 million, compared with a TTM value of $34.4 million through Sep 2025, changed N/A, and an annual FY2024 reading of $4.2 million, changed N/A over the prior year.
  • Change in Inventory was $8.6 million for Q3 2025 at Autolus Therapeutics, down from $11.4 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $11.4 million in Q2 2025 and bottomed at $4.2 million in Q4 2024.